Back to Sites

Chiangrai Prachanukroh Hospital

Site Number

5116

Address

Chiang Rai Regional Hosp. CRS
Chiangrai Prachanukroh Hospital
1039 Sathanpayaban Road
Chiang Rai, Chiang Rai 57000
Thailand

IMPAACT Members at this Site

Suree KaewPanan CAB Member

Wannipha Yenjal Clinical Research Assistant

Pra-Ornsuda Sukrakanchana CRS Coordinator

Supaporn Utsaha CRS Coordinator

Gonzague J. Jourdain CRS Leader

Pacharee Kantipong CRS Leader

Jane E. Bupp DAIDS PO

Jullapong Achalapong Investigator

Chulapong Chanta Investigator

Rawiwan Hansudewechakul Investigator

Pradthana Ounchanum Investigator

Chaiporn Kamluang Local Laboratory

Yupawan Thaweesombat Pharmacist of Record

Ruethai Wongchai Research Assistant

Sangdao Somsri Staff

Suporn Watanaporn Staff

Tim Cressey Study Coordinator

Chaniporn Yodsuwan Study Coordinator

Studies at this Site

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

38637

Research Area

Therapeutics

Study Status

Enrolling

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Two to Less Than 13 Years of Age with and without HIV

DAIDS Number

38747

Research Area

Tuberculosis

Study Status

In Development

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

38693

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2017: MOCHA

DAIDS Number

30070

Research Area

Therapeutics

Study Status

Closed to Accrual

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

38932

Research Area

Therapeutics

Study Status

Enrolling